COMPANIES / CIK 0001544227
Tempest Therapeutics, Inc.
Filing history
Available filing events · –
Events by filing month
Select a month to filter the list.
16 events
1–16 of 16
Ms. Constance Ames — appointed as Chief Financial Officer
Mr. Nicholas Rossettos — appointed as Chief Financial Officer
Purchase by Angel Matthew
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 231,482
- Price per share
- Unreported
Purchase by Angel Matthew
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 231,482
- Price per share
- Unreported
Purchase by Angel Matthew
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 231,482
- Price per share
- 2.16
Grant, award or other acquisition by Yee John D.
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 25,000
- Price per share
- 0.00
Grant, award or other acquisition by Richey William Drake
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 25,000
- Price per share
- 0.00
Grant, award or other acquisition by Trojanowski Justin
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 22,000
- Price per share
- 0.00
Grant, award or other acquisition by Maestas Nicholas
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 140,000
- Price per share
- 0.00
Purchase by Angel Matthew
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 231,482
- Price per share
- 2.16
Grant, award or other acquisition by Angel Matthew
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 269,621
- Price per share
- 0.00
Grant, award or other acquisition by Simantov Ronit
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 1,230
- Price per share
- 0.00
Grant, award or other acquisition by RAAB MICHAEL
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 1,230
- Price per share
- 0.00
Grant, award or other acquisition by NICHOL GEOFFREY
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 1,230
- Price per share
- 0.00
Grant, award or other acquisition by Pellizzari Christine A
Tempest Therapeutics, Inc.
Transaction date
- Shares
- 1,230
- Price per share
- 0.00